Skip to main content
Figure 3 | Cardiovascular Diabetology

Figure 3

From: Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study

Figure 3

Effects of exenatide on 24-hour and nocturnal systolic blood pressure (SBP). Changes over the study period (A and B), at endpoint (C and D), and for subjects with high (>120 mm Hg) baseline SBP values (E and F) are shown. Seventeen exenatide-treated subjects and 11 placebo-treated subjects had high baseline 24-hour SBP values (E), and 13 exenatide-treated subjects and 9 placebo-treated subjects had high baseline nocturnal SBP values (F). P = NS. Intent-to-treat sample population and mean ± SE are shown. Last observation carried forward for Plots C through F.

Back to article page